EARLY ALZHEIMER'S DISEASE
Clinical trials for EARLY ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for EARLY ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Alzheimer's pill shows promise in slowing cognitive decline for High-Risk group
Disease control CompletedThis Phase 3 trial tested whether an oral medication called ALZ-801 could slow Alzheimer's progression in people with early-stage disease who carry two copies of the APOE4 gene, which increases risk. 325 participants took either the drug or a placebo twice daily for 78 weeks whil…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated Apr 02, 2026 00:42 UTC
-
Alzheimer's pill targets brain plaques in High-Risk patients
Disease control CompletedThis study tested whether an oral medication called ALZ-801 could affect biological markers of Alzheimer's disease in people with early symptoms who carry specific genetic risk factors (APOE4 gene). The 84 participants took the pill twice daily for up to four years while research…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC